What is Factor Xii Deficiency?

Factor XII deficiency, also known as Hageman factor deficiency, is a rare blood disorder where the body does not produce enough of a specific protein called Factor XII. This protein plays a role in the blood clotting process. The deficiency can be inherited, meaning it is passed down from parents to their children through genes. In some cases, Factor XII deficiency can also occur without a known genetic cause.

This condition is usually asymptomatic and often discovered incidentally during routine blood tests. While it can lead to abnormal bleeding in some individuals, most people with Factor XII deficiency do not experience any negative health effects. Understanding the causes of this deficiency is crucial for proper management and monitoring of affected individuals.

What Are the Symptoms of Factor Xii Deficiency

Factor XII deficiency, also known as Hageman factor deficiency, is a rare blood disorder that may not cause any symptoms in most cases. However, some individuals with this condition may experience abnormal bleeding, such as easy bruising, nosebleeds, or prolonged bleeding after injury or surgery. In severe cases, Factor XII deficiency can lead to excessive bleeding that is difficult to control. It is important for individuals with this condition to work closely with their healthcare provider to manage and monitor any bleeding symptoms effectively.

Easy bruising and prolonged bleeding after minor injuries are common symptoms of Factor XII deficiency.
Excessive bleeding following surgery or dental procedures can be a sign of Factor XII deficiency.
Women with Factor XII deficiency may experience heavy or prolonged menstrual bleeding.
Nosebleeds that are difficult to control may indicate the presence of Factor XII deficiency.
Individuals with Factor XII deficiency may develop excessive bleeding in the joints, leading to joint pain and swelling.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Factor Xii Deficiency

Factor XII deficiency, also known as Hageman factor deficiency, is a rare genetic condition characterized by low levels or dysfunction of Factor XII, a clotting protein. The main cause of this deficiency is inherited gene mutations that affect the production or function of Factor XII. These mutations can be passed down from parents to their children in an autosomal recessive pattern. In some cases, acquired Factor XII deficiency can occur due to certain medical conditions or medications that interfere with the production or activity of Factor XII.

Factor XII deficiency can be caused by genetic mutations affecting the production or function of Factor XII in the blood.
Acquired conditions like liver disease or certain medications can lead to Factor XII deficiency by interfering with coagulation processes.
Autoimmune disorders may trigger the immune system to attack Factor XII, resulting in a deficiency of this clotting factor.
In rare cases, Factor XII deficiency can be linked to conditions such as amyloidosis or certain types of cancers affecting blood production.
Factor XII deficiency can also be associated with underlying health issues like inflammatory bowel disease or chronic kidney disease, impacting clotting mechanisms.

Types Of Factor Xii Deficiency

Factor XII deficiency, also known as Hageman factor deficiency, can be classified into two main types: Type I and Type II. Type I deficiency involves reduced levels of Factor XII in the blood, leading to a higher risk of bleeding and abnormal clotting. In contrast, Type II deficiency is characterized by impaired function of Factor XII despite normal levels present, resulting in similar bleeding issues. Both types can manifest with varying severity and may be asymptomatic or present with symptoms such as easy bruising, nosebleeds, or prolonged bleeding after injury or surgery.

Type I Factor XII deficiency is the most common form, characterized by low levels of Factor XII in the blood.
Type II Factor XII deficiency is a rare form where the quality of Factor XII is impaired despite normal levels.
Homozygous Factor XII deficiency occurs when both parents pass on a defective Factor XII gene to their child.
Heterozygous Factor XII deficiency is when an individual inherits one defective gene from one parent, resulting in milder symptoms.
Acquired Factor XII deficiency can develop later in life due to conditions like liver disease or certain medications.
Asymptomatic Factor XII deficiency may be discovered incidentally through blood tests without causing any noticeable symptoms.

Risk Factors

Factor XII deficiency is a rare inherited blood disorder characterized by low levels of Factor XII, a blood clotting protein. Risk factors for Factor XII deficiency include a family history of the condition, as it is passed down through generations. People with the deficiency may be prone to excessive bleeding or have a history of unexplained blood clots.

Additionally, certain medical conditions, such as autoimmune diseases or liver disease, may also increase the risk of Factor XII deficiency. While the disorder is generally mild and may not cause symptoms in many cases, individuals with a family history or related medical conditions should be aware of the potential risks associated with Factor XII deficiency.

Family history of Factor XII deficiency increases the risk of inheriting the condition.
Certain genetic mutations can predispose individuals to Factor XII deficiency.
Being of Ashkenazi Jewish descent is associated with a higher prevalence of Factor XII deficiency.
Age can be a risk factor, with Factor XII deficiency often diagnosed in adulthood.
Autoimmune diseases, such as systemic lupus erythematosus, may be linked to Factor XII deficiency.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Factor Xii Deficiency

Factor XII deficiency, a rare inherited blood disorder, is diagnosed through a series of tests. Initially, a detailed medical history is taken to identify any symptoms or family history of bleeding disorders. Blood tests, including coagulation studies such as activated partial thromboplastin time (aPTT) and Factor XII activity assay, are then conducted to measure clotting factors' levels.

Genetic testing may be performed to identify specific gene mutations associated with the deficiency. Additionally, a physical examination and further specialized tests may be done to rule out other potential causes of abnormal bleeding.

Diagnosis of Factor XII deficiency typically involves laboratory tests to measure Factor XII levels in the blood.
Blood coagulation tests, such as the activated partial thromboplastin time (aPTT), can help identify abnormalities associated with Factor XII deficiency.
Genetic testing may be performed to detect specific mutations or variations in the F12 gene linked to Factor XII deficiency.
Detailed medical history and physical examination are crucial in the diagnostic process of Factor XII deficiency.
Additional tests, such as mixing studies and Factor XII-specific assays, may be conducted to confirm the diagnosis.
Collaborating with hematologists or coagulation specialists is essential for a comprehensive evaluation and management of Factor XII deficiency.

Treatment for Factor Xii Deficiency

Factor XII deficiency, a rare inherited blood disorder, may not require treatment unless a person experiences abnormal bleeding. Treatments aim to manage symptoms and prevent complications rather than cure the deficiency itself. Options include managing bleeding episodes with clot-promoting medications like desmopressin or plasma-derived clotting factors.

In severe cases, patients may require regular infusions of plasma or factor XII concentrate. Additionally, genetic counseling and testing can help individuals understand their risk and make informed decisions about family planning. Close monitoring and collaboration with healthcare providers are crucial for effectively managing Factor XII deficiency.

Factor XII deficiency, also known as Hageman factor deficiency, is a rare inherited blood disorder. Treatment options for Factor XII deficiency primarily focus on managing symptoms and preventing complications. In most cases, no specific treatment is necessary unless the individual experiences excessive bleeding or undergoes surgery. During surgical procedures, clotting factors may be administered to prevent bleeding complications.

For individuals at risk of excessive bleeding, desmopressin can be used to stimulate the release of von Willebrand factor and factor VIII. Regular monitoring of factor XII levels and close medical supervision are crucial in managing Factor XII deficiency. In severe cases, plasma products containing clotting factors may be administered to control bleeding episodes effectively. Genetic counseling is recommended for individuals with Factor XII deficiency to understand the

Find Our Specialists

Book Doctor Appointment